Status:
COMPLETED
AL-15469A for the Treatment of Bacterial Conjunctivitis
Lead Sponsor:
Alcon Research
Conditions:
Bacterial Conjunctivitis
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
Eligibility Criteria
Inclusion
- Signs \& Symptoms of conjunctivitis
Exclusion
- Under 1 mo. age
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00331916
Start Date
November 1 2005
Last Update
September 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
US
Fort Worth, Texas, United States, 76134